In this clip, the panel discusses the implications of health reform on the treatment of hepatitis C virus (HCV), including what is needed to improve outcomes. This includes educating primary care physicians about how the Affordable Care Act requires health plans to pay for the costs of testing and screening for risk factors of HCV.
In this clip, the panel discusses the implications of health reform on the treatment of hepatitis C virus (HCV), including what is needed to improve outcomes. This includes educating primary care physicians about how the Affordable Care Act requires health plans to pay for the costs of testing and screening for risk factors of HCV. Screening is recommended for those at risk, including those who have used injection drugs.
However, changes won’t occur overnight, and the recommendations have not yet been implemented by all health plans, nor have they been for all ages (eg, those born between1946-1964). Additionally, unlike many other screening tests, the HCV antibody tests are not as expensive as other screening tests such as mammographies or colonoscopies. In some cases, it’s what the patients do with the information post-screening that matters most.
Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures
December 19th 2025Limiting health-related social needs screening to lower-income areas would reduce screening burdens; however, this study found a 2-stage screening approach based on geography to be suboptimal.
Read More